Literature DB >> 11305078

Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women.

D A Doherty1, K M Sanders, M A Kotowicz, R L Prince.   

Abstract

We examined the incidence of fragility fractures in Australian women 50 years of age and over using a Markov process with Monte Carlo simulations. The lifetime risks and the risks of sustaining first and subsequent clinically diagnosed fractures at osteoporotic sites were estimated according to age, nursing home entry and mortality rates. Hip and spine fractures were evaluated individually and fractures of humerus, forearm, wrist, ribs, pelvis, upper leg (excluding proximal femur) and tibia/fibula were considered in combination. The model predicted that 42.1% of women aged 50 years will sustain at least one fracture in their remaining lifetime, of whom half are expected to sustain multiple fractures. The lifetime risks of sustaining hip, clinical spine and other fractures were 17.0%, 9.6% and 30.4%, with the risks of multiple fractures at these sites estimated at 19.5%, 39.7% and 35.7% respectively. The proportion of women expected to sustain their first fracture increased from 1.9% of the population under 55 years of age up to 49.1% of women over 89 years of age. The 5-year age-specific risks of sustaining any subsequent fractures increased from 2.8% of women under the age of 55 years to 61.6% for women age 89 years and over. The increased risks of new fractures following a first fracture lead to a considerable burden of multiple fractures.

Entities:  

Mesh:

Year:  2001        PMID: 11305078     DOI: 10.1007/s001980170152

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  32 in total

1.  Fractures in osteoporosis: the challenge for the new millennium.

Authors:  J Y Reginster; N Sarlet; M P Lecart
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

2.  Detection of osteoporotic vertebral fractures using multidetector CT.

Authors:  J S Bauer; D Müller; A Ambekar; M Dobritz; M Matsuura; F Eckstein; E J Rummeny; T M Link
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

3.  A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures.

Authors:  D Bliuc; J A Eisman; J R Center
Journal:  Osteoporos Int       Date:  2006-06-21       Impact factor: 4.507

4.  Baseline age and time to major fracture in younger postmenopausal women.

Authors:  Margaret Lee Gourlay; Robert A Overman; Jason P Fine; Kristine E Ensrud; Carolyn J Crandall; Margery L Gass; John Robbins; Karen C Johnson; Erin S LeBlanc; Catherine R Womack; John T Schousboe; Andrea Z LaCroix
Journal:  Menopause       Date:  2015-06       Impact factor: 2.953

5.  Bone fractures and incident epithelial ovarian cancer in a prospective cohort study.

Authors:  Kim N Danforth; Catherine Schairer; Arthur Schatzkin; James V Lacey
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

6.  Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?

Authors:  J D Adachi; C C Kennedy; A Papaioannou; G Ioannidis; W D Leslie; V Walker
Journal:  Osteoporos Int       Date:  2009-03-11       Impact factor: 4.507

7.  Prediction of incident osteoporotic fractures in elderly women using the free estradiol index.

Authors:  A Devine; I M Dick; S S Dhaliwal; R Naheed; J Beilby; R L Prince
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

8.  Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis.

Authors:  Robert Lindsay; Simon Pack; Zhengqing Li
Journal:  Osteoporos Int       Date:  2004-09-28       Impact factor: 4.507

9.  Bisphosphonate use and subsequent hip fracture in South Korea.

Authors:  Y-K Lee; Y-C Ha; H J Choi; S Jang; C Park; Y-T Lim; C S Shin
Journal:  Osteoporos Int       Date:  2013-05-17       Impact factor: 4.507

10.  Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial.

Authors:  Debby den Uyl; Piet P M M Geusens; Frank N R van Berkum; Harry H M L Houben; Max C Jebbink; Willem F Lems
Journal:  Clin Rheumatol       Date:  2009-12-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.